Skip to main content Skip to navigation

Research Exchange

Novel Drug for Cancer Immunotherapy that Targets Phosphatidylserine

Type

grant

Grant Number

R43 CA257721-01A1

A global leader in the fight against gynecologic cancer

LIVING LAB

Join the Living Lab Our Team Governance & Ethics Social Media Toolkit

DISCOVERY LAB

Discovery Lab How It Works Upcoming Webinars Contribute Data

ABOUT

About OCRA Get Involved Make a Donation Contact Us

© 2025 Ovarian Cancer Research Alliance, Inc.

Privacy Terms Accessibility

Novel Drug for Cancer Immunotherapy that Targets Phosphatidylserine